CCRN
CCRN
Cross Country Healthcare, Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $236.76M ▼ | $21.84M ▼ | $-82.93M ▼ | -35.03% ▼ | $-2.56 ▼ | $10.99M ▲ |
| Q3-2025 | $250.05M ▼ | $56.9M ▼ | $-4.77M ▲ | -1.91% ▲ | $-0.15 ▲ | $-993K ▲ |
| Q2-2025 | $274.07M ▼ | $61.86M ▲ | $-6.66M ▼ | -2.43% ▼ | $-0.2 ▼ | $-1.08M ▼ |
| Q1-2025 | $293.41M ▼ | $59.63M ▼ | $-490K ▲ | -0.17% ▲ | $-0.02 ▲ | $4.42M ▲ |
| Q4-2024 | $309.94M | $65.42M | $-3.75M | -1.21% | $-0.12 | $3.98M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $108.74M ▲ | $448.95M ▼ | $126.13M ▼ | $322.82M ▼ |
| Q3-2025 | $99.13M ▲ | $538.23M ▼ | $130.09M ▼ | $408.14M ▼ |
| Q2-2025 | $81.19M ▲ | $553.82M ▼ | $141.58M ▼ | $412.24M ▼ |
| Q1-2025 | $80.7M ▼ | $576.24M ▼ | $158.03M ▼ | $418.21M ▼ |
| Q4-2024 | $81.63M | $589.25M | $170.29M | $418.96M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $0 ▲ | $18.24M ▼ | $-2.12M ▲ | $-6.52M ▼ | $9.61M ▼ | $16.12M ▼ |
| Q3-2025 | $-4.77M ▲ | $20.11M ▲ | $-2.19M ▼ | $-6K ▲ | $17.94M ▲ | $17.92M ▲ |
| Q2-2025 | $-6.66M ▼ | $4.22M ▼ | $-1.97M ▼ | $-1.76M ▲ | $496K ▲ | $2.25M ▼ |
| Q1-2025 | $-490K ▲ | $5.68M ▼ | $-1.89M ▲ | $-4.72M ▼ | $-936K ▼ | $3.79M ▼ |
| Q4-2024 | $-3.75M | $24.23M | $-2.53M | $-4.08M | $17.61M | $21.7M |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Other Services | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ |
Q3 2024 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Cross Country Healthcare, Inc.'s financial evolution and strategic trajectory over the past five years.
Key positives include a strong balance sheet with net cash, ample liquidity, and modest debt, which provides resilience and flexibility. The company has an established brand in healthcare staffing, a large and diverse clinician network, and deep relationships with health systems built over many years. Its proprietary Intellify platform and broader digital investments give it a clear technology story and the potential for more recurring, higher-margin revenues. Positive operating and free cash flow in the latest period, despite poor accounting earnings, offer additional financial breathing room.
Major concerns center on the reported collapse in revenue and large accounting losses, which, if representative of reality rather than data quirks, would indicate extreme operational stress and an unsustainable business model. High ongoing operating costs relative to current reported revenue, significant asset exposure to goodwill and intangibles, and the lack of visible capital spending all add to the risk profile. Competitive pressure from larger staffing and tech-enabled rivals, health system cost-cutting, and potential regulatory changes could further compress margins and volumes. Execution risk around scaling Intellify, entering new verticals, and possibly licensing the platform also remains significant.
The forward view is mixed and highly dependent on clarifying the true underlying revenue and profitability trajectory. On one hand, a strong cash position, low leverage, and meaningful technology assets position Cross Country to adapt, invest, and pursue growth in workforce solutions, platform expansion, and adjacent staffing markets. On the other hand, the current income statement snapshot and intense industry competition suggest that the path forward may involve continued restructuring, margin pressure, and the need to prove that Intellify-driven solutions can deliver durable growth and profitability. Overall, the company has strategic tools and financial resources, but the near-to-medium-term outlook remains uncertain until the disconnect between accounting losses, reported revenue, and positive cash flow is better understood.
About Cross Country Healthcare, Inc.
https://www.crosscountryhealthcare.comCross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company operates in two segments, Nurse and Allied Staffing and Physician Staffing.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $236.76M ▼ | $21.84M ▼ | $-82.93M ▼ | -35.03% ▼ | $-2.56 ▼ | $10.99M ▲ |
| Q3-2025 | $250.05M ▼ | $56.9M ▼ | $-4.77M ▲ | -1.91% ▲ | $-0.15 ▲ | $-993K ▲ |
| Q2-2025 | $274.07M ▼ | $61.86M ▲ | $-6.66M ▼ | -2.43% ▼ | $-0.2 ▼ | $-1.08M ▼ |
| Q1-2025 | $293.41M ▼ | $59.63M ▼ | $-490K ▲ | -0.17% ▲ | $-0.02 ▲ | $4.42M ▲ |
| Q4-2024 | $309.94M | $65.42M | $-3.75M | -1.21% | $-0.12 | $3.98M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $108.74M ▲ | $448.95M ▼ | $126.13M ▼ | $322.82M ▼ |
| Q3-2025 | $99.13M ▲ | $538.23M ▼ | $130.09M ▼ | $408.14M ▼ |
| Q2-2025 | $81.19M ▲ | $553.82M ▼ | $141.58M ▼ | $412.24M ▼ |
| Q1-2025 | $80.7M ▼ | $576.24M ▼ | $158.03M ▼ | $418.21M ▼ |
| Q4-2024 | $81.63M | $589.25M | $170.29M | $418.96M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $0 ▲ | $18.24M ▼ | $-2.12M ▲ | $-6.52M ▼ | $9.61M ▼ | $16.12M ▼ |
| Q3-2025 | $-4.77M ▲ | $20.11M ▲ | $-2.19M ▼ | $-6K ▲ | $17.94M ▲ | $17.92M ▲ |
| Q2-2025 | $-6.66M ▼ | $4.22M ▼ | $-1.97M ▼ | $-1.76M ▲ | $496K ▲ | $2.25M ▼ |
| Q1-2025 | $-490K ▲ | $5.68M ▼ | $-1.89M ▲ | $-4.72M ▼ | $-936K ▼ | $3.79M ▼ |
| Q4-2024 | $-3.75M | $24.23M | $-2.53M | $-4.08M | $17.61M | $21.7M |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Other Services | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ |
Q3 2024 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Cross Country Healthcare, Inc.'s financial evolution and strategic trajectory over the past five years.
Key positives include a strong balance sheet with net cash, ample liquidity, and modest debt, which provides resilience and flexibility. The company has an established brand in healthcare staffing, a large and diverse clinician network, and deep relationships with health systems built over many years. Its proprietary Intellify platform and broader digital investments give it a clear technology story and the potential for more recurring, higher-margin revenues. Positive operating and free cash flow in the latest period, despite poor accounting earnings, offer additional financial breathing room.
Major concerns center on the reported collapse in revenue and large accounting losses, which, if representative of reality rather than data quirks, would indicate extreme operational stress and an unsustainable business model. High ongoing operating costs relative to current reported revenue, significant asset exposure to goodwill and intangibles, and the lack of visible capital spending all add to the risk profile. Competitive pressure from larger staffing and tech-enabled rivals, health system cost-cutting, and potential regulatory changes could further compress margins and volumes. Execution risk around scaling Intellify, entering new verticals, and possibly licensing the platform also remains significant.
The forward view is mixed and highly dependent on clarifying the true underlying revenue and profitability trajectory. On one hand, a strong cash position, low leverage, and meaningful technology assets position Cross Country to adapt, invest, and pursue growth in workforce solutions, platform expansion, and adjacent staffing markets. On the other hand, the current income statement snapshot and intense industry competition suggest that the path forward may involve continued restructuring, margin pressure, and the need to prove that Intellify-driven solutions can deliver durable growth and profitability. Overall, the company has strategic tools and financial resources, but the near-to-medium-term outlook remains uncertain until the disconnect between accounting losses, reported revenue, and positive cash flow is better understood.

CEO
Kevin Cronin Clark
Compensation Summary
(Year 2025)
Upcoming Earnings
ETFs Holding This Stock
Summary
Showing Top 3 of 87
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Grade Summary
Showing Top 4 of 4
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:5.92M
Value:$59.06M
BLACKROCK, INC.
Shares:2.62M
Value:$26.14M
BLACKROCK FUND ADVISORS
Shares:2.61M
Value:$26.07M
Summary
Showing Top 3 of 260

